Dosimetry
| Patient–cycle | ||||||||
| Low | Intermediate–low | Intermediate–high | High | |||||
| Tumor load | P1-C1 (Gy/GBq) | P1-C2 (Gy/GBq) | P2-C1 (Gy/GBq) | P2-C2 (Gy/GBq) | P3-C1 (Gy/GBq) | P3-C2 (Gy/GBq) | P4-C1 (Gy/GBq) | P4-C2 (Gy/GBq) |
| Kidney | 0.55 | 0.56 | 1.14 | 0.82 | 0.81 | 0.76 | 0.62 | 0.76 |
| Red marrow | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.03 |
| Parotid gland | 2.2 | 1.16 | 1.03 | 0.82 | 1.26 | 1.3 | 1.27 | 1.17 |
| Submandibular gland | 1.3 | 1.69 | 1.26 | 0.97 | 1.37 | 1.31 | 1.82 | 2.13 |
| Liver | 0.09 | 0.1 | 0.07 | 0.06 | 0.09 | 0.1 | 0.16 | 0.13 |
| Spleen | 0.19 | 0.15 | 0.26 | 0.14 | 0.11 | 0.13 | 0.28 | 0.27 |
| Bladder wall | 0.03 | 0.16 | 0.16 | 0.17 | 0.29 | 0.23 | 0.41 | 0.36 |
| Metastases (mean) | 6.1 | 22.8 | 15.3 | 14 | ||||
| Effective dose equivalent (mSv/GBq) | 81.8 | 77 | 114 | 82.5 | 96.3 | 91.2 | 126 | 111 |
| Effective dose (mSv/GBq) | 48.2 | 46.5 | 37.2 | 43.9 | 58.3 | 54.3 | 83,4 | 65 |